Prospective Study of Sequential Reduction in Immunosuppression, Interferon Alpha-2B, and Chemotherapy for Posttransplantation Lymphoproliferative Disorder-Reference-Cited by-同舟云学术

Prospective Study of Sequential Reduction in Immunosuppression, Interferon Alpha-2B, and Chemotherapy for Posttransplantation Lymphoproliferative Disorder

Published:2008-07-27 Issue:2 Volume:86 Page:215-222
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Swinnen Lode J.,LeBlanc Michael,Grogan Thomas M.,Gordon Leo I.,Stiff Patrick J.,Miller Alan M.,Kasamon Yvette,Miller Thomas P.,Fisher Richard I.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference24 articles.

1. Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients.;Milpied;Ann Oncol,2000

2. Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: Results of a prospective multicenter phase 2 study.;Choquet;Blood,2006

3. Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD).;Oertel;Am J Transplant,2005

4. Aggressive treatment for postcardiac transplant lymphoproliferation.;Swinnen;Blood,1995

5. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: Acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation.;Hanto;N Engl J Med,1982

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trial;Blood;2024-07-25

2. Treatment of Epstein-Barr Virus infection in immunocompromised patients;Biochemical Pharmacology;2024-07

3. Post‐transplant lymphoproliferative disorder associated Epstein‐Barr virus DNAemia after liver transplantation in children: Experience from single center;Journal of Medical Virology;2024-06

4. The IPTA Nashville consensus conference on post‐transplant lymphoproliferative disorders after solid organ transplantation in children: IV‐consensus guidelines for the management of post‐transplant lymphoproliferative disorders in children and adolescents;Pediatric Transplantation;2024-05-29

5. Pediatric Kidney Transplantation: Cancer and Cancer Risk;Seminars in Nephrology;2024-01